| Original language | English |
|---|---|
| Pages (from-to) | 40-44 |
| Number of pages | 5 |
| Journal | Japanese Journal of Cancer and Chemotherapy |
| Volume | 46 |
| Issue number | 1 |
| Publication status | Published - Jan 1 2019 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Oncology
- Cancer Research
Cite this
How has the treatment outcomes for advanced renal cell carcinomalmproved in the 10 years after approval of targeted therapy ? / Imada, Kenjiro; Eto, Masatoshi.
In: Japanese Journal of Cancer and Chemotherapy, Vol. 46, No. 1, 01.01.2019, p. 40-44.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - How has the treatment outcomes for advanced renal cell carcinomalmproved in the 10 years after approval of targeted therapy ?
AU - Imada, Kenjiro
AU - Eto, Masatoshi
PY - 2019/1/1
Y1 - 2019/1/1
UR - http://www.scopus.com/inward/record.url?scp=85061569472&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85061569472&partnerID=8YFLogxK
M3 - Article
C2 - 30765640
AN - SCOPUS:85061569472
VL - 46
SP - 40
EP - 44
JO - Japanese Journal of Cancer and Chemotherapy
JF - Japanese Journal of Cancer and Chemotherapy
SN - 0385-0684
IS - 1
ER -